Who should be vaccinated?
Two vaccines are available in the United States to help prevent meningococcal disease.1 2 These are called:
- Menomune (MPSV4)
- Menactra (MCV4).
Menactra is recommended for anyone between 11 and 18.1 2 It should be given as early as possible, usually when a child reaches 11 or 12.
You may also be advised to have this vaccine if you:
- Are a high school freshman
- Are a college freshman living in a dormitory
- Are a military recruit
- Have a damaged spleen (or you've had your spleen removed)
- Have problems with your immune system
- Are traveling to countries where there's an outbreak of meningococcal disease
- Might have been exposed to meningitis during an outbreak.
Menomune is recommended for:
- Children between 2 and 10
- Adults over 55.
Sources for the information on this page:
- Centers for Disease Control and Prevention. Meningococcal disease. Available at http://www.cdc.gov (accessed on 2 June 2008).
- Centers for Disease Control and Prevention. Notice to Readers: Revised Recommendations of the Advisory Committee on Immunization Practices to Vaccinate All Persons Aged 11--18 Years with Meningococcal Conjugate Vaccine. August 2007. Available at http://www.cdc.gov/MMWR (accessed on 2 June 2008).
- U.S. Food and Drug Administration. FDA and CDC issue alert on Menactra meningococcal vaccine and Guillain Barre Syndrome. Available at http://www.fda.gov (accessed on 2 June 2008).
This information was last updated in Jun 08, 2008
![]() |
This information is for educational use only, and is not a substitute for prompt professional medical advice. Readers should always consult a physician or other professional for advice and treatment. ©BMJ Publishing Group Limited 2008. All rights reserved. |












